Positions

Overview

  • Dr. Hoesley received his medical degree from the University of South Florida and completed his internship, internal medicine residency, chief residency, and infectious disease fellowship at the University of Alabama at Birmingham. He joined the UAB faculty in 1999 and served as the internal medicine clerkship director for 7 years prior to becoming the associate dean for undergraduate medical education in 2008. In July 2015, Dr. Hoesley became the senior associate dean for medical education and chair of the Department Medical Education. In this role, he provides oversight for the undergraduate and graduate medical education programs as well as continuing medical education and medical student services in the School of Medicine.

    His research interests include the development of a safe and effective microbicide to prevent sexual transmission of HIV. He is the UAB site leader for the NIH-funded Microbicide Trials Network. Dr. Hoesley is the current chair of the University Hospital Pharmacy and Therapeutic Committee.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings 2019
    2019 Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women 2019
    2019 Pharmacokinetics of dapivirine transfer into blood plasma, breast milk, and cervicovaginal fluid of lactating women using the dapivirine vaginal ring 2019
    2019 A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027 2019
    2018 Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience 2018
    2016 First-in-human trial of MIV-150 and zinc acetate coformulated in a carrageenan gel: Safety, pharmacokinetics, acceptability, adherence, and pharmacodynamics 2016
    2016 Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States 2016
    2016 In vitro exposure to PC-1005 and cervicovaginal lavage fluid from women vaginally administered PC-1005 inhibits HIV-1 and HSV-2 infection in human cervical mucosa 2016
    2016 Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial 2016
    2016 Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center 2016
    2015 Mucosal effects of tenofovir 1% gel 2015
    2015 Integration of gross anatomy in an organ system-based medical curriculum: Strategies and challenges 2015
    2015 Phase 1 safety, pharmacokinetics, and pharmacodynamics of dapivirine and maraviroc vaginal rings: A double-blind randomized trial 2015
    2014 Barrier Methods for Human Immunodeficiency Virus Prevention 2014
    2014 A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010) 2014
    2013 A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007) 2013
    2013 Adherence and acceptability in MTN 001: A randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women 2013
    2013 MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments 2013
    2010 Anal-rectal cytology: Correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients 2010
    2010 Human immunodeficiency virus infection in alabama women: Sociodemographic, behavioral, and reproductive health characteristics and factors associated with lack of Human immunodeficiency virus-1 viral control 2010
    2010 University of Alabama School of Medicine 2010
    2009 Internal medicine clerkship characteristics associated with enhanced student examination performance 2009
    2009 Novel methodology for antiretroviral quantitation in the female genital tract 2009
    2008 Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies 2008
    2008 Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital 2008
    2007 USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections 2007
    2006 Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center 2006
    2006 Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates 2006
    2006 Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women 2006
    2005 Trends in cancer incidence rates among HIV-infected patients [3] (multiple letters) 2005
    2004 Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002 2004
    2004 High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus 2004
    2004 University of alabama school of medicine. 2004
    2004 University of alabama school of medicine. 2004
    2004 Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic 2004
    2003 A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: Correlations with CD4 cell count and plasma HIV-1 RNA level 2003
    2002 Comparative analysis of commercial assays for the detection and quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C 2002
    2001 Viral latency--the papillomavirus model. 2001
    2000 Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice 2000
    1998 Use of statistics and scientific inference: Odds ratios, likelihood ratio, and receiving operating characteristic curves [2] (multiple letters) 1998

    Chapter

    Year Title Altmetric
    2010 Bartonellosis (carrión’s disease).  903-904. 2010

    Principal Investigator On

  • Leadership and Operations Center (LOC): Microbicide Trials Network - Protocol Funds MTN 038  awarded by Magee-Womens Research Institute (MWRI) 2018 - 2019
  • Leadership and Operations Center (LOC): Microbicide Trials Network - Protocol Funds: MTN-037  awarded by Magee-Womens Research Institute (MWRI) 2018 - 2019
  • Leadership and Operations Center (LOC): Microbicide Trials Network - Protocol Funds MTN-035  awarded by Magee-Womens Research Institute (MWRI) 2018 - 2019
  • Leadership and Operations Center (LOC): Microbicide Trials Network - Protocol Funds: MTN -038  awarded by Magee-Womens Research Institute (MWRI) 2017 - 2018
  • MTN 035 Acceptability, Tolerability, and Adherence Of Three Rectal Microbicide Dosage Forms Among HIV Seronegative Men And Transgender Women  awarded by Magee-Womens Research Institute (MWRI) 2017 - 2018
  • MTN 037 Protocol Funds  awarded by Magee-Womens Research Institute (MWRI) 2017 - 2018
  • Leadership and Operations Center (LOC): Microbicide Trials Network (MTN 036 Protocol Funds)  awarded by Magee-Womens Research Institute (MWRI) 2016 - 2018
  • Leadership and Operations Center (LOC): Microbicide Trials Network - MTN 030  awarded by Magee-Womens Research Institute (MWRI) 2016 - 2018
  • MTN 026 Protocol Funds  awarded by Magee-Womens Research Institute (MWRI) 2015 - 2018
  • Leadership and Operations Center (LOC): Microbicide Trials Network  awarded by Magee-Womens Research Institute (MWRI) 2014 - 2017
  • Leadership and Operations Center (LOC): Microbicide Trials Network, MTN-029  awarded by Magee-Womens Research Institute (MWRI) 2015 - 2016
  • Equal Access Birmingham I-Stat Grant  awarded by Community Foundation of Greater Birmingham 2015 - 2016
  • Leadership and Operations Center (LOC): Microbicides Trials Network  awarded by Magee-Womens Research Institute (MWRI) 2014 - 2015
  • Equal Access Birmingham Dispensary Funding  awarded by Community Foundation of Greater Birmingham 2013 - 2015
  • PC-558 A Phase 1, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Acceptibility of PC-1005 (MIV-150/ZA in a Carrageenan Vehicle) Microbicide Gel Formulation in HIV- Seronegative Women  awarded by Population Council 2014 - 2015
  • A Double-Blind, Randomized, Placebo-Controlled Phase I/II Trial to Evaluate the Safety of Dapivirine Gel 4759, 0/05% 2.5g and Dapivirine Gel 4789, 0.05% 2.5g Formulations as Compared to the Vaginal Hec-Based Universal Placebo Gel, 2.5g in Healthy HIV-Negative Women  awarded by INTERNATIONAL PARTNERSHIP FOR MICROBICIDES, INC. 2009 - 2011
  • Teaching Activities

  • 06-299A - EAB PATIENT PANEL ASSOCIATE (Spring Term 2018) 2018
  • STP299AV - Comparison of International Medical Education in the Netherlands (Fall Term 2017) 2017
  • STP2999FL - MY PATH TO MEDICAL SCHOOL AND MY FUTURE CAREER (Spring Term 2017) 2017
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2015) 2015
  • STP2999CZ - CDC: INFECTIOUS DISEASE DATABASE DEVELOPMENT (Fall Term 2015) 2015
  • STP2147 - MENTAL HEALTH MANAGEMENT AND CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2015) 2015
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2015) 2015
  • STP2147 - MENTAL HEALTH MANAGEMENT AND CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2015) 2015
  • STP2147 - MENTAL HEALTH MANAGEMENT AND CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2015) 2015
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2015) 2015
  • PUH697 - Practice Placement (Fall Term 2014) 2014
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2014) 2014
  • STP2147 - MENTAL HEALTH MANAGEMENT AND CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2014) 2014
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2014) 2014
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2014) 2014
  • STP2147 - MENTAL HEALTH MANAGEMENT AND CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2014) 2014
  • STP2147 - MENTAL HEALTH MANAGEMENT AND CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2014) 2014
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2014) 2014
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2013) 2013
  • STP2143 - EAB CLINICAL MANAGEMENT (Fall Term 2013) 2013
  • STP2142 - EAB CLINICAL SKILLS (Fall Term 2013) 2013
  • 95-406 - CLINICAL PATHOLOGY (Fall Term 2012) 2012
  • 06-402E - BASIC SCIENCE ELECTIVE (Fall Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Fall Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Fall Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Fall Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2011) 2011
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2011) 2011
  • STP2102 - OREGON SEARCH PROGRAM (Fall Term 2010) 2010
  • STP2103 - OREGON SEARCH PROGRAM (Fall Term 2010) 2010
  • STP2999 - SPECIAL TOPIC EXPERIENCE (Fall Term 2010) 2010
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2010) 2010
  • 06-402E - BASIC SCIENCE ELECTIVE (Spring Term 2010) 2010
  • 10-458 - PREPARATION FOR INTERNSHIP AND RESIDENCY TRAINING (Spring Term 2008) 2008
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2008) 2008
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2008) 2008
  • 28-517 - MEDICINE RESEARCH (Spring Term 2008) 2008
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2008) 2008
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2008) 2008
  • 28-517 - MEDICINE RESEARCH (Fall Term 2007) 2007 - 2008
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-517 - MEDICINE RESEARCH (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-517 - MEDICINE RESEARCH (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-517 - MEDICINE RESEARCH (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Fall Term 2007) 2007
  • 02-280 - MEDICINE CLERKSHIP (Spring Term 2007) 2007
  • 10-458 - PREPARATION FOR INTERNSHIP AND RESIDENCY TRAINING (Spring Term 2007) 2007
  • 02-280 - MEDICINE CLERKSHIP (Spring Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2007) 2007
  • 28-517 - MEDICINE RESEARCH (Spring Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2007) 2007
  • 02-280 - MEDICINE CLERKSHIP (Spring Term 2007) 2007
  • 28-422 - INFECTIOUS DISEASES (Spring Term 2007) 2007
  • Education And Training

  • UAB Hospital, Internship 1993
  • UAB Hospital, Residency 1995
  • UAB Hospital, Postdoctoral Fellowship 1998
  • Full Name

  • Craig Hoesley